Introduction Bone strength describes the resistance of bone against mechanical failure. Bone strength depends on both the amount of bone and the bone's quality, and the bone strength may be looked upon as a relevant parameter to judge an osteosynthesis' stability. Information about bone strength was barely available intraoperatively in the past. The previous work of our group reported on development and laboratory evaluation of mechanical torque measurement as a method for the intraoperative quantiWcation of bone strength. With the clinical series presented here we intend to verify that the im gesamten Text DensiProbe™ instrumentation for intraoperative torque measurement and the related measurement method are eligible for intraoperative use based on the following criteria: application of the method may not create complications, the measurement can be performed by the surgeon himself and may only cause a limited increase in the procedure time.
DHS
® were included in the study after having received informed consent. Any medication and comorbidity that might have inXuenced bone quality or bone mineral density (BMD) in these patients was documented. Bone strength was intraoperatively measured with DensiProbe ® . Complications that were obviously related with torque measurement were documented as well as any deviation from the suggested procedure; 6 and 12 weeks postoperative followup included clinical and radiological examination. The time required for torque measurement, the overall operating time and the number of persons present in the operating room were protocolled. BMD values of the contralateral femoral neck were postoperatively assessed by dual energy X-ray absorptiometry (DEXA) and compared to intraoperative peak torque values measured by DensiProbe ® . Results No major complication was observed during intraoperative application of DensiProbe ® by trained surgeons. The unintended extraction of the guide wire together with the torque measurement probe was reported only once and is looked upon as a minor complication. Fracture healing was uneventful in all patients. The mean time for torque measurement was 2.35 § 0.9 min accounting for 2.2 § 1.1% of total surgery time. The presence of an additional person was not required to perform torque measurement but to protocol the data. There was a tendency towards correlation between BMD values of the femoral neck and intraoperative peak torque values. Discussion The data presented clearly indicate that the DensiProbe ® instrumentation and measurement principle are eligible for routine intraoperative use by trained surgeons. Interpretation of possible correlations between BMD values measured by means of DEXA and the Peak Torque values assessed by DensiProbe ® has to be considered very carefully, because BMD and Peak Torque analyse bone at a diVerent scale. Only within the framework of a multicenter
Introduction
Proper use of implants and augmentation techniques [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] dedicated for fracture Wxation in osteoporotic bone follows previous estimation of an osteosynthesis' stability. Several parameters inXuence the overall osteosynthesis' stability, such as fracture type, quality of fracture reduction [13] , implant position [14, 15] and bone strength [16] . All parameters, except for the bone strength, can be rated preoperatively or intraoperatively by the surgeon.
Bone strength, however, depends on the structural and material properties of bone [16, 17] . In the past there was no measurement principle or instrumentation available in the market for the intraoperative quantiWcation of bone strength. Instead, bone strength is indirectly estimated by bone mineral density (BMD) using dual-energy X-ray absorptiometry (DEXA). Since DEXA-measured BMD accounts for only 60-70% of the variation in bone strength, some important factors are not captured by DEXA. Moreover, DEXA measurement is not routinely available preoperatively or intraoperatively [18] but can clearly be performed "noninvasively". DEXA measurements might therefore help to estimate the fracture risk of a patient, to put the diagnosis of osteoporosis and to indicate or to monitor an antiresorptive drug therapy of osteoporosis.
On the other hand the assessment of intrinsic mechanical quality of bony tissue should provide a better estimation of bone strength [17] . This option might come into play in patients who have suVered from a fracture and where the surgeon plans to perform osteosynthesis. While performing surgery, the surgeon gets direct access to the bone. Previous work from our group [19] describes development and laboratory evaluation of a new method for intraoperative measurement of bone strength. The torque to breakaway of trabecular bone is measured with the DensiProbe ® instrumentation. This should provide immediate and more accurate information about bone strength than the postoperative DEXA scan could. The dimensions and the application scheme of DensiProbe ® are adapted for the use with the standard DHS ® implant.
Requirements
Intraoperative application of DensiProbe ® instrumentation requires perfect compliance with the hygienic standards in the operating theatre. Furthermore there should be minimal potential for complications due to the intraoperative measurement of bone strength. The surgeon should be able to perform the measurement independently on his own, and the extra time needed for the measurement should be minimal when compared to the overall length of the procedure.
With the pilot series presented here we intended to verify the following hypothesis:
• The DensiProbe ® instrumentation is eligible for intraoperative use based on the criteria mentioned above.
Within our stepwise approach to introduce the intraoperative measurement of bone strength into clinical routine, this would mean clariWcation of the method for evaluation within a multicenter trial.
Materials and methods

Enrollment of patients
Following protocol approval by the local ethical committee, patients with proximal femoral fractures having given their informed consent were enrolled in the study from December 2006 until May 2007. The inclusion criteria were deWned as the presence of either a stable or unstable pertrochanteric femoral fracture (classiWed according to AO as 31A1-A3) [20] or a lateral femoral neck fracture (classiWed according to Garden as type 1-4) [21] eligible for stabilization with DHS ® . The lower age limit for inclusion was 35, in order to assure a wide spectrum of bone qualities was measured during the study. Exclusion criteria were preexisting local infections of the aVected hip and pathologic fractures due to primary malignancies or metastatic lesions in the proximal femur. Upon inclusion in the study, all patients were screened for conditions potentially impairing bone strength such as previous surgery in the proximal femur and the presence of major and minor risk factors for osteoporosis (i.e., personal or familiar history of fragility fractures, presence of osteoporotic vertebral fractures, treatment with steroids and anticonvulsants, malabsorption syndrome, physical inactivity, cigarette smoking, low body weight and advanced age). Moreover intake of basic osteoporosis prophylaxis (calcium plus vitamin D) or speciWc antiosteoporotic therapy (bisphosphonates, SERM, parathormon) was recorded.
Mechanical torque measurement
Bone strength was measured according to our recently described measurement principle [19] , which is fully adapted to stabilization of proximal femoral fracture using the DHS ® implant. Fracture reduction and exposure were done according to the guidelines for DHS ® insertion. Under Xuoroscopic control, a K-wire for subsequent guided insertion of the DHS ® screw was drilled in the subchondral bone of the femoral head reaching a central-to-inferior position in the AP view and a central-to-posterior position in the axial view. The length of this guide was measured. A second K-wire was inserted in parallel but cranially to the Wrst one in order to prevent rotation of the head-neck fragment during subsequent torque measurement and insertion of the DHS ® screw (Fig. 1a, b) . Using the 8.0 mm cannulated spiral drill guided by the lower K-wire, the lateral cortex of the femur was opened. As an adaptation to the standard technique, the spiral drill was inserted to a depth 45 mm less than the subchondral bone in order to avoid removal of trabecular bone at the site of the following measurement procedure (Fig. 2a, b) . After removal of the spiral drill, a custom-made cannulated mechanical probe was inserted over the pre-positioned guide wire into the femoral head. Measurement of bone strength happened at the tip of the rod-like mechanical probe. The tip consists of a wing blade with 6.5 mm outer diameter and 20.0 mm blade length (Fig. 3 ). To position this wing blade at the intended site of the DHS ® screw tip at a depth 15 mm less than the guide wire length, a few gentle hammer blows were applied (Fig. 4a) . A scale at the tail of the probe veriWed the correct insertion depth of the probe (Fig. 4b) . The Wnal position of the measurement probe was documented by Xuoroscopy (Fig. 4c) . Then, a handhold with an intrinsic calibrated digital torque meter (AO Development, Davos, Switzerland) was locked at the lateral end of the probe, which was subsequently rotated around its longitudinal axis (Fig. 5a ). The peak torque until complete breakaway of the cancellous bone between the wings of the mechanical probe was recorded by the digital torque meter located in the handhold (Fig. 5b) . The digital meter registered the torque values in the range from 1 to 8 Nm. A minimal torque of 1 Nm has to be applied in order to trigger the measurement process. This lower limit was chosen in order to prevent the unintended activation of torque recording. If the torque necessary to break away the cancellous bone exceeded 8 Nm, the system would unlock allowing free rotation to prevent rotation of the head and neck fragment. The data were processed with MATLAB Software (The MathWorks, Massachusetts, USA). The surgeon performing the measurement procedure was blinded to the result. Then the probe was removed and the cannulated spiral drill was reinserted over the guide wire still in place. The drilling was then completed to a depth 10 mm less then the subchondral bone as described in the standard operation procedure for DHS ® implantation. The subsequent procedure of DHS ® implantation was completed without further adaptations. For each patient, the time needed for insertion of the measurement Fig. 1 a, b Under Xuoroscopic control a guide wire is inserted to reach the subchondral bone of the femoral head. A second guide wire is drilled in cranially to prevent rotation of the head neck fragment during subsequent DHS ® implantation. The length of the guide wire is measured Fig. 2 a, b Reduced pertrochanteric fracture with the guide wire and second cranially placed k-wire to prevent rotation pin in place. The canulated spiral drill is inserted to a depth 45 mm less than the guide wire blade as well as the mechanical measurement process and the removal of the measurement blade were recorded and related to the total surgery time from skin incision to skin closure.
Complications
Penetration of the guide wire into the pelvis during insertion of the blade, secondary loss of fracture reduction, wound infection or delayed fracture healing were the worst complications that could be imagined owing to the intraoperative use of DensiProbe ® . Preventive measures were taken as a result of a risk management process. However, these events may not be prevented in all situations by the measurements taken and they were therefore carefully monitored during the pilot series. Extraction of the guide wire with the blade was also expected, but was looked upon as a minor complication. Moreover, any deviation of the intraoperative procedure from the intended scheme of application described above was documented and analyzed for the potential of a complication.
BMD measurement and postoperative follow-up
Fracture reduction and screw position was recorded on plain radiographs in all patients prior to mobilization under full weight bearing. Patients were then clinically and radiographically followed up at 6 and 12 weeks following surgery for presence of postoperative infection, fracture union, screw loosening or cut out. In the course of postoperative rehabilitation, all patients underwent standard dual energy X-ray absorptiometry (DEXA) to measure BMD of the spine as well as the femoral neck, intertrochanteric and trochanteric area of contralateral unfractured proximal femur. The presence of the implant impaired measurement of the fractured side. But because there is tight correlation between the BMD values of both the proximal femurs, hence [22] BMD measurement at the contralateral unfractured side is justiWed. The BMD values of the femoral neck were then compared to intraoperatively recorded peak torque values. 
Results
Patient population
In the inclusion period, 10 patients (six females, four males, mean age: 57 § 16 years) with four pertrochanteric fractures (three, AO31A1; one, AO31A2) and six lateral femoral neck fractures (two Garden 1; three Garden 2; one Garden 4) were enrolled in the study. Six fractures were located on the left side and four fractures on the right side. Table 1 lists all 10 patients with demographic data, type and cause of fracture and presence of BMD modifying conditions. Seven fractures were caused by a minor trauma, whereas three fractures were the result of an intermediate trauma (fall from a bike, severe direct trauma to the hip during a Wght). Four patients reported previous fragility fractures, but no patient indicated familiar burden for such a fracture. Vertebral compression fractures were detected on the chest X-ray in two patients.
Three patients exhibited long-term medication with systemic steroids. Of these, two patients suVered from autoimmune disease (myasthenia gravis and colitis ulcerosa respectively) and one had a history of bone marrow transplantation due to acute myeloic leukemia. Another two patients indicated regular treatment with topical steroids because of asthma. One patient reported regular intake of anticonvulsants in the context of hereditary epilepsia. Three patients were heavy smokers (>20 PY) and another three patients exhibited a BMI lower than 18 kg/m 2 . Treatment with calcium/vitamin D had been installed in one patient and no patient was on bisphosphonates.
Peak torque measurement
No major complication occurred during intraoperative torque measurement. In one case, the guide wire for screw insertion was accidentally pulled out when the cannulated probe was removed from the femoral head. Reinsertion of the guide wire was not problematic. No loss of previously achieved fracture reduction or iatrogenic fracture occurred during the measurement procedures. In the postoperative period, none of the patients showed clinical signs of a surgical site infection. Moreover, fracture healing was uneventful in all the patients. All the fractures united within three months. No screw loosening or cut out was recorded. Fig. 5 a, b The handhold with its intrinsic digital torque meter is mounted and the probe is rotated along its longitudinal axis. Peak torque to breakaway cancellous bone is registered by the digital torque meter in the handhold
The intraoperative application of the method by trained surgeons never required the presence of any additional person except for data protocol.
The mean time for torque measurement was 2.35 § 0.9 min accounting for 2.2 § 1.1% of total surgery time. The peak torque as recorded by the digital torque meter ranged from 1.2 to 7.8 Nm with a mean of 3.8 § 2.3 Nm.
BMD measurement by dual energy X-ray absorptiometry and postoperative follow-up Postoperative DEXA scans were performed in all but one (patient number seven) who refused investigation of bone mineral density despite previous acceptance with the study protocol. However, this patient received a standard radiographic follow-up.
The mean BMD values of the spine were 0.822 § 0.12 g/ cm 2 . One patient showed normal BMD values of the spine. Osteoporotic (t value <¡2.5) and osteopenic spine BMD values (t value between ¡1 and ¡2.5) were detected in four patients, respectively. The mean BMD values of the femoral neck were 0.694 § 0.187 g/cm 2 . In detail, the BMD values at the femoral neck qualiWed for osteoporosis in four patients, osteopenia in three patients and normal values in two patients. Overall, seven patients were diagnosed with osteoporosis, two with osteopenia and one patient had normal BMD values. The BMD values of the femoral neck of each of the nine patients having undergone DEXA were plotted against intraoperatively measured peak torque values (see Fig. 6 ). As shown in the graph, there is some tendency towards correlation of peak torque value and BMD.
Discussion
Despite the limited number of patients included in the pilot study so far, the data presented clearly indicate that the measurement principle and the DensiProbe ® instrumentation are eligible for routine intraoperative use by trained surgeons within the framework of a multicenter study. A slight prolongation of the operating time as well as the absence of any relevant complication that could be related to the application of our measurement probe will assure acceptance by the participating surgeons. Figure 6 presents peak torque values measured with DensiProbe ® and BMD values measured by DEXA in the same patients. These data have been included because they outline a number of open questions that might be studied in the future by means of the DensiProbe ® method:
• Are we able to identify the cut-oV value for peak torque when the application of advanced Wxation principles is considered? • What is the inXuence of an antiresorptive therapy on bone strength?
The interpretation of possible correlations between these data, however, has to be considered very carefully, because BMD and peak torque analyze bone at two diVerent scales.
The concept of a material's strength is well known from material sciences. For a simple object composed of a uniform material, a break occurs when the load applied creates a stress that exceeds the strength of the material. But bone is a complex composite material with a number of mechanical properties, and no single property adequately describes bone strength [16] . Being aware of this limitation, the strength concept from material sciences might also be applied to bone.
The major noninvasive measurement available for the early diagnosis of osteoporosis is currently the measurement of areal BMD by DEXA. Indeed, BMD is considered a major determinant of bone strength from a macroscopic point of view. Ex vivo studies performed on human material have indicated an excellent correlation between BMD of the proximal femur and bone strength as evaluated by shear test of the femoral neck. BMD does not only integrate the amount of mineral but also indirectly the dimension of bone. BMD predicts approximately 66-74% of the variation in bone strength. BMD is a surrogate determinant of bone strength to judge the overall status of a skeleton or of a bone as a whole.
On the other hand, the knowledge of bone strength might also help to isolate those patients at risk for loss of reduction, or penetration of a Wxation device as complications of open reduction and internal Wxation. This information may guide the surgeon in selecting the most appropriate fracture Wxation device or technique: This may include hydroxyapatite coated screws or pins which were demonstrated to improve implant osteointegration in various animal [23] [24] [25] [26] studies and to enhance Wxation strength in osteoporotic bone in randomized controlled clinical trials [27] [28] [29] . As an alternative to the use of particular implants designed for osteoporotic bone, the surgeon may consider to augment the anchorage of standard implants by the injection of methacrylate bone cement according to our recently published protocol [12] . This easy to apply technique has shown to enhance implant anchorage in osteoporotic cadaver femurs. The associated risk of embolism and clinically relevant tissue necrosis may be lowered by the suggested elution of fat and bone marrow prior to cement application which allows smooth cement distribution in a small volume around the screw tip [4, 30] . Besides these techniques enhancing Wxation strength, the surgeon may also decide on a more protective postoperative management. In this context the concept of bone strength is applied to the bone volume right next to the implant.
All terms describing bone strength can be derived from the force-displacement diagram that results from a mechanical test of loading a bone specimen until it breaks [16] . Laboratory studies have therefore been performed where bone became subject of material testing [31, 32] . These test principles can provide good information about bone strength but can only be applied to small samples of bone and are not available in routine clinical use. Nevertheless, these studies form the basis for the idea to perform a simple mechanical test in order to get better information about bone strength. This idea was Wrst followed in the Weld of spinal surgery. Several groups have intended to predict pedicle screw loosening or cut out by means of previous intraoperative mechanical analysis of the bone [33] [34] [35] . These series have shown uneven results. From our point of view, the pedicle is not an ideal model to apply mechanical measurement of bone strength. Whenever the probe comes into contact with cortical bone, the mechanical competence is completely diVerent from the trabecular bone. This means, the premises to apply a strength concept, e.g., the existence of a homogeneous material is not valid.
We are going to evaluate our measurement principle within the femoral head where we can be pretty sure, the measurement probe does not get into contact with cortical bone. This means, the premise to work with a "strength concept" e.g., the existence of a "homogeneous material" is fulWlled.
Within our stepwise approach to introduce the intraoperative measurement of bone strength into clinical routine, the next step will be a multicenter trial aiming to include several hundreds of patients from diVerent hospitals. Thereby, we may prove that the method can also be applied securely and with reproducible results by such surgeons who were not involved in the development of the concept from the beginning.
Inclusion of suYcient patients to calculate the method's predictive value towards implant cut-out as a single risk factor or in combination with other risk factors can only be achieved by means of a multi center study. Further studies investigating the mechanisms by which drugs reduce fracture risk might also beneWt when intraoperative measurement of bone strength by means of DensiProbe ® becomes available.
